References

  1. Crohn’s Colitis Canada. https://crohnsandcolitis.ca. Accessed October 13, 2023.
  2. REMICADE® Product Monograph. June 6, 2019.
  3. INFLECTRA® Product Monograph. August 28, 2019.
  4. RENFLEXIS™ Product Monograph. April 5, 2019.
  5. HUMIRA® Product Monograph. June 25, 2019.
  6. STELARA® Product Monograph. January 28, 2019.
  7. ENTYVIO® Product Monograph. January 28, 2019.
  8. SIMPONI® Product Monograph. November 6, 2018.
  9. XELJANZ® Product Monograph. July 2, 2019.
  10. RINVOQ® Product Monograph. October 2023
  11. ZEPOSIA® Product Monograph. April 7,2022.
  12. OMVOH™ Product Monograph. July 20, 2023.
  13. VELSIPITY Product Monograph. Jan 30, 2024.
  14. Vaccination Guide for Immunosuppressed Patients with Inflammatory Bowel Disease. https://www.crohnsandcolitis.ca/Crohns_and_Colitis/documents/research/CANIBD/Guide-to-Vaccination-CANIBD.pdf. Accessed October 13, 2023.
  15. Laube R et al. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut 2023; 72(6):1040-1053.
  16. Brondfield M, Mahadevan U. Inflammatory bowel disease in pregnancy and breastfeeding. Nat Rev Gastroenterol Hepatol. 2023;20: 504-523.
This tool is intended for Canadian Healthcare Professionals. Copyright © 2025 CANIBD Canadian IBD Nurses.

Contact Us    Provider Resources     References

CANIBD and Crohn's and Colitis Canada do not accept any responsibility or liability for the accuracy, content, completeness, legality, or reliability of the information contained in this Service. The content is not intended to diagnose, treat, cure or prevent disease. Content was developed in 2024 and is provided for informational purposes only.